ArticleNutrients2025

Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal Impairment.

Ludovica Verde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.